AE/2795/2025 - CABOZANTINIB (80MG+20MG) CP

ID 12712938 · Portal BASE
Price
Base Price
€73,200 .00
Effective Price
€73,200 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Company
Dates
Publication
21 Jan 2026
Celebration
07 Nov 2025
Contracting Entity
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE
NIF 506361616
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 125 · CRITICAL RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
86
Supplier
85
Number of Awards
7
Rule
A1 repeat direct award: 7 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
21 Jan 2026
Signing Date
07 Nov 2025
Days Late
75
Rule
A2/A3 late publication: 75 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
73200.0
Threshold
75000.0
Rule
A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06